Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment

NCT00874211 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00874211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00874211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Completed
Start date
December 31, 2008
Completion date
June 30, 2019
Enrollment
3,571 (actual)
Sites
453

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lung cancer, metastatic cancer, multiple myeloma, plasma cell neoplasm, prostate cancer, unspecified adult solid tumor, protocol specific